These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1156016)

  • 1. General pharmacology of a new analgesic-AP-237.
    Carrano RA; Kimura KK; Landes RC; McCurdy DH
    Arch Int Pharmacodyn Ther; 1975 Jan; 213(1):28-40. PubMed ID: 1156016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analgesic and tolerance studies with AP-237, a new analgesic.
    Carrano RA; Kimura KK; McCurdy DH
    Arch Int Pharmacodyn Ther; 1975 Jan; 213(1):41-57. PubMed ID: 1156018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug activity as a function of the experimental pathological state].
    Quevauviller A
    Actual Pharmacol (Paris); 1967; 20():133-67. PubMed ID: 4388945
    [No Abstract]   [Full Text] [Related]  

  • 4. General pharmacological properties of the new vasodilator flosequinan.
    Ikezono K; Fujita S; Umezato M; Hosoki E; Toba Y; Kusunoki A; Shintani S
    Arzneimittelforschung; 1992 Oct; 42(10):1200-11. PubMed ID: 1472141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacology of a new potent analgesic].
    Herrmann M; Steinbrecher W; Heldt W
    Arzneimittelforschung; 1970 Aug; 20(8):977-83. PubMed ID: 5536518
    [No Abstract]   [Full Text] [Related]  

  • 6. General pharmacological properties of the main metabolite of flosequinan.
    Fujita S; Ikezono K; Umezato M; Hosoki E; Toba Y; Ishikawa M; Kusunoki A; Shintani S
    Arzneimittelforschung; 1992 Oct; 42(10):1212-22. PubMed ID: 1335257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The general pharmacology of a novel antitussive compound RU 20201.
    Pickering RW; James GW
    Arzneimittelforschung; 1979; 29(4):642-6. PubMed ID: 314807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General pharmacological profile of the new anti-ulcer drug 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl]-amino-N -methylbenzamide.
    Hirohashi M; Takasuna K; Kasai Y; Usui C; Tamura K; Kojima H
    Arzneimittelforschung; 1993 May; 43(5):569-77. PubMed ID: 8329002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological testing of a new anti-inflammatory agent: 1-(m-trifluoromethylphenyl)-N-nitroso anthranilic acid].
    Zoni G; Molinari ML; Banfi S
    Farmaco Sci; 1971 Jun; 26(6):525-46. PubMed ID: 5561809
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological study of a new non-steroidal anti-inflammatory drug: protacine (CR 604).
    Rovati AL; Vidal y Plana RR; Casula PL; Bizzarri D; Makovec F; Setnikar I
    Arzneimittelforschung; 1979; 29(8):1116-22. PubMed ID: 315235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General pharmacology of cis-malonato[4R,5R)-4,5-bis-(aminomethyl)-2-isopropyl-1,3- dioxolane]platinum(II).
    Kim DK; Ahn JS; Ryu G; Kim KH; Park CW; Kim MS; Chung MH; Shin SG; Suh YH; Kim YS
    Arzneimittelforschung; 1994 Sep; 44(9):1080-8. PubMed ID: 7986249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on analgesic agents. VI. Analgesic effect of 1-butyryl-4-cinnamylpiperazine hydrochloride.
    Irikura T; Nishino K; Ito N; Ito M; Ohkubo H
    Jpn J Pharmacol; 1970 Jun; 20(2):287-93. PubMed ID: 5311564
    [No Abstract]   [Full Text] [Related]  

  • 13. Gastrointestinal prokinetic and antiemetic effects of a new substituted pyrimidinO 6553 (2-methylamino-4-N-methylpiperazino-5-thiomethyl-6-chloropyrimidine hydrochloride).
    Loiseau G; Millischer R; Donadieu AM; Marquet JP
    Arzneimittelforschung; 1977; 27(3):606-11. PubMed ID: 577427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [General pharmacologic studies on the analgesic flupirtine].
    Jakovlev V; Achterrath-Tuckermann U; von Schlichtegroll A; Stroman F; Thiemer K
    Arzneimittelforschung; 1985; 35(1):44-55. PubMed ID: 4039152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contribution to the pharmacodynamic study of 1,2-diphenyl-3,5-dioxo-4-n-butyl-pyrazolidinopiperazine].
    La Barre J; Derouaux G; Oleffe-Koopmansch S
    Arch Int Pharmacodyn Ther; 1966 Apr; 160(2):265-83. PubMed ID: 5954030
    [No Abstract]   [Full Text] [Related]  

  • 16. [General pharmacological properties of methiazinic acid (16091 RP)].
    Julou L; Guyonnet JC; Ducrot R; Bardone MC; Detaille JY; Laffargue B
    Arzneimittelforschung; 1969 Aug; 19(8):1198-206. PubMed ID: 4390179
    [No Abstract]   [Full Text] [Related]  

  • 17. The pharmacology of 1,6-dimethyl-3-carbethoxy-4-oxo-6,7,8,9-tetrahydro-homopyrimidazol-methylsulphate (MZ-144), a new, potent, non-narcotic analgesic. 3. Analysis of the central and peripheric effects.
    Knoll J; Fürst S; Mészáros Z
    Arzneimittelforschung; 1971 May; 21(5):727-33. PubMed ID: 4998916
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties.
    Yamasaki T; Kojima H; Tanaka M; Aibara S; Hirohashi M; Kasai Y; Tsubokawa M; Watanabe K; Akashi A
    Arzneimittelforschung; 1981; 31(4):707-15. PubMed ID: 6113834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Piperazine-derivatives. II. Effect of piperazine-derivatives].
    Lányi K; Erdélyi I; Institoris E; Tardos L; Szabó Z
    Arzneimittelforschung; 1968 Nov; 18(11):1431-5. PubMed ID: 5755908
    [No Abstract]   [Full Text] [Related]  

  • 20. Tiapamil, a new calcium antagonist. 2. Further pharmacological characterization and toxicology.
    Eigenmann R; Gerold M; Hefti F; Jovanovic D; Haeusler G
    Arzneimittelforschung; 1981; 31(9):1401-10. PubMed ID: 7197946
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.